Your browser doesn't support javascript.
loading
GloPID-R report on Chikungunya, O'nyong-nyong and Mayaro virus, part I: Biological diagnostics.
Pezzi, L; Reusken, C B; Weaver, S C; Drexler, J F; Busch, M; LaBeaud, A D; Diamond, M S; Vasilakis, N; Drebot, M A; Siqueira, A M; Ribeiro, G S; Kohl, A; Lecuit, M; Ng, L F P; Gallian, P; de Lamballerie, X.
Affiliation
  • Pezzi L; Unité des Virus Émergents (UVE: Aix-Marseille Univ-IRD 190-Inserm 1207-IHU Méditerranée Infection), Marseille, France; EA7310, Laboratoire de Virologie, Université de Corse-Inserm, Corte, France. Electronic address: laura.pezzi3@studio.unibo.it.
  • Reusken CB; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands; Department Viroscience, Erasmus University Medical Center, Rotterdam, the Netherlands.
  • Weaver SC; Institute for Human Infections and Immunity and Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, USA.
  • Drexler JF; Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Virology, 10117 Berlin, Germany; German Centre for Infection Research (DZIF), Germany.
  • Busch M; Blood Systems Research Institute, San Francisco, and Department of Laboratory Medicine, University of California, San Francisco, USA.
  • LaBeaud AD; Department of Pediatrics, Division of Infectious Diseases, Stanford University School of Medicine, Stanford, USA.
  • Diamond MS; Department of Medicine, and The Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs, Washington University School of Medicine, St. Louis, USA; Department of Molecular Microbiology, and The Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Prog
  • Vasilakis N; Department of Pathology, Institute of Human Infection and Immunity, University of Texas Medical Branch, Galveston, USA.
  • Drebot MA; Zoonotic Diseases and Special Pathogens, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Canada.
  • Siqueira AM; Instituto Nacional de Infectologia Evandro Chagas - Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
  • Ribeiro GS; Gonçalo Moniz Institute, Oswaldo Cruz Foundation, and Federal University of Bahia, Salvador, Brazil.
  • Kohl A; MRC-University of Glasgow Centre for Virus Research, Glasgow, UK.
  • Lecuit M; Institut Pasteur, Biology of Infection Unit, Inserm U1117, Paris Descartes University, Departement of Infectious Diseases and Tropical Medicine, Necker-Enfants Malades University Hospital, APHP, IHU Imagine, Paris, France.
  • Ng LFP; Singapore Immunology Network, Agency for Science, Technology and Research (A*STAR), Singapore.
  • Gallian P; Établissement Français du Sang Alpes Méditerranée, Marseille, France.
  • de Lamballerie X; Unité des Virus Émergents (UVE: Aix-Marseille Univ-IRD 190-Inserm 1207-IHU Méditerranée Infection), Marseille, France.
Antiviral Res ; 166: 66-81, 2019 06.
Article in En | MEDLINE | ID: mdl-30905821
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Alphavirus Infections / Communicable Diseases, Emerging / Chikungunya Fever Type of study: Diagnostic_studies / Guideline / Prognostic_studies Limits: Animals / Humans Language: En Journal: Antiviral Res Year: 2019 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Alphavirus Infections / Communicable Diseases, Emerging / Chikungunya Fever Type of study: Diagnostic_studies / Guideline / Prognostic_studies Limits: Animals / Humans Language: En Journal: Antiviral Res Year: 2019 Type: Article